BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026)
BioXcel Therapeutics' (BTAI) quarterly Current Taxes came in at $46000.0 in Q1 2026, down 29.23% year-on-year from $65000.0 in Q1 2025, and up 43.75% quarter-over-quarter from $32000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026) Analysis & Trends
BioXcel Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $46000.0 for Q1 2026.
- On a quarterly basis, Current Taxes fell 29.23% year-over-year to $46000.0 in Q1 2026; TTM through Mar 2026 was $46000.0, a 29.23% decrease from a year earlier, with the FY2025 full-year figure at $32000.0, down 64.84% from the prior year.
- Current Taxes improved to $46000.0 in Q1 2026 per BTAI's latest filing, from $32000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $529000.0 in Q3 2022 and bottomed at $32000.0 in Q4 2025.
- The 5-year median for Current Taxes is $103000.0 (2025), against an average of $147705.9.
- Across the five-year window, Current Taxes jumped 165.83% in 2022 and sank 74.86% in 2023, its largest moves.
- Year by year, Current Taxes stood at $82000.0 in 2022, then jumped by 41.46% to $116000.0 in 2023, then fell by 21.55% to $91000.0 in 2024, then sank by 64.84% to $32000.0 in 2025, then surged by 43.75% to $46000.0 in 2026.
- Per Business Quant, the three latest BTAI Current Taxes figures stand at $46000.0 (Q1 2026), $32000.0 (Q4 2025), and $103000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | BioXcel Therapeutics | 10.62 Mn | 10.62 Mn | -77,000.00 | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 212,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 529,000.00 |
| Jun 30, 2022 | 258,000.00 |
| Mar 31, 2022 | 366,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 254,000.00 |